Respiratory failure & ventilation

Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome

Am J Respir Crit Care MedPublished Secondary analysis of the ROSE randomised trial

Authors' conclusion

These findings suggest that the mortality benefit of NMB varies with baseline Ers.

Study context

Population
Patients with acute respiratory distress syndrome (ARDS)
Comparison
Early neuromuscular blockade (NMB) vs no early NMB; effect moderation by baseline Ers, ventilatory ratio and plasma biomarkers
Methodological detailsBayesian logistic regression
  • Bayesian logistic regression

Primary result

As reported in the abstract

Moderation of NMB effect on 90-day mortality
Probability of mortality benefit with NMB increased with higher baseline Ers: posterior probability of interaction
92%
Ers interaction OR
0.76 (90% CrI 0.59-0.99)
Ers ⩾2 cm H2O/(ml/kg): posterior probability of benefit
96%
Ers ⩾2 cm H2O/(ml/kg): median absolute risk reduction
9% (90% CrI 0.5-17.9)
Ventilatory ratio: posterior probability of interaction (no meaningful variation)
62%
Receptor for advanced glycation end-products: posterior probability of interaction
12%
Tumor necrosis factor receptor-1: posterior probability of interaction
18%
IL-6: posterior probability of interaction
44%
IL-8: posterior probability of interaction
22%

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. Published 1 June 2025. doi:10.1164/rccm.202406-1231oc

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.